These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18161629)

  • 21. In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds.
    Pamula E; Menaszek E
    J Mater Sci Mater Med; 2008 May; 19(5):2063-70. PubMed ID: 17968505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis.
    Zhang Y; Zale S; Sawyer L; Bernstein H
    J Biomed Mater Res; 1997 Mar; 34(4):531-8. PubMed ID: 9054536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
    Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
    J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.
    Marinina J; Shenderova A; Mallery SR; Schwendeman SP
    Pharm Res; 2000 Jun; 17(6):677-83. PubMed ID: 10955840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
    Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
    J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam.
    Holy CE; Dang SM; Davies JE; Shoichet MS
    Biomaterials; 1999 Jul; 20(13):1177-85. PubMed ID: 10395386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC; Yeh MK; Coombes AG; Davis SS
    Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
    Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
    J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.
    Wu L; Ding J
    Biomaterials; 2004 Dec; 25(27):5821-30. PubMed ID: 15172494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films.
    Lu L; Garcia CA; Mikos AG
    J Biomed Mater Res; 1999 Aug; 46(2):236-44. PubMed ID: 10380002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLG microsphere size controls drug release rate through several competing factors.
    Berkland C; Kim K; Pack DW
    Pharm Res; 2003 Jul; 20(7):1055-62. PubMed ID: 12880292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Submicronparticles from biodegradable polymers.
    Jobmann M; Rafler G
    Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.
    Zhang Y; Sophocleous AM; Schwendeman SP
    Pharm Res; 2009 Aug; 26(8):1986-94. PubMed ID: 19533307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
    Shao PG; Bailey LC
    Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.